Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
(NY:
ANRO
)
13.49
-1.11 (-7.60%)
Official Closing Price
Updated: 7:00 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about ANRO
Alto Neuroscience Announces Data Presentations Highlighting Late-Stage Clinical Pipeline and Robust Platform at Upcoming Scientific Conferences
May 09, 2024
From
Alto Neuroscience, Inc.
Via
Business Wire
Alto Neuroscience Announces Positive Phase 1 Results for ALTO-101, a Novel PDE4 Inhibitor in Development for Schizophrenia
April 23, 2024
From
Alto Neuroscience, Inc.
Via
Business Wire
Alto Neuroscience Announces Initiation of Phase 2 Study of ALTO-203 in Patients with Major Depressive Disorder
April 03, 2024
From
Alto Neuroscience, Inc.
Via
Business Wire
Alto Neuroscience Reports Full Year 2023 Financial Results and Recent Business Highlights
March 21, 2024
From
Alto Neuroscience, Inc.
Via
Business Wire
Alto Neuroscience Appoints Maha Radhakrishnan, M.D., to Board of Directors
March 11, 2024
From
Alto Neuroscience, Inc.
Via
Business Wire
Alto Neuroscience to Participate in Upcoming Investor Conferences
March 07, 2024
From
Alto Neuroscience, Inc.
Via
Business Wire
Alto Neuroscience to Present at the TD Cowen 44th Annual Healthcare Conference
February 27, 2024
From
Alto Neuroscience, Inc.
Via
Business Wire
Alto Neuroscience Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
February 06, 2024
From
Alto Neuroscience, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.